Literature DB >> 21537047

Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.

Vittorio Fusco, Claudia Galassi, Alfredo Berruti, Libero Ciuffreda, Cinzia Ortega, Giovannino Ciccone, Alberto Angeli, Oscar Bertetto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21537047     DOI： 10.1200/JCO.2011.35.1551

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

Review 1.  Osteochemonecrosis: an overview.

Authors:  John Hellstein
Journal:  Head Neck Pathol       Date:  2014-11-20

2.  Osteonecrosis of the jaw from bone anti-resorptives: impact of skeletal site-dependent mesenchymal stem cells.

Authors:  So Akintoye
Journal:  Oral Dis       Date:  2013-10-07       Impact factor: 3.511

3.  Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?

Authors:  Vittorio Fusco; Alberto Bedogni; Alfredo Addeo; Giuseppina Campisi
Journal:  Support Care Cancer       Date:  2016-03-09       Impact factor: 3.603

4.  CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.

Authors:  Akira Baba; Tazuko K Goto; Hiroya Ojiri; Mutsumi Takagiwa; Chiho Hiraga; Masahiro Okamura; Sho Hasegawa; Yumi Okuyama; Nobuhiro Ogino; Hideomi Yamauchi; Yuko Kobashi; Shinji Yamazoe; Yohei Munetomo; Takuji Mogami; Takeshi Nomura
Journal:  Dentomaxillofac Radiol       Date:  2018-02-13       Impact factor: 2.419

5.  Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws?

Authors:  Hiroaki Shimamoto; Tristan R Grogan; Tomomi Tsujimoto; Naoya Kakimoto; Shumei Murakami; David Elashoff; Tara L Aghaloo; Sotirios Tetradis
Journal:  Dentomaxillofac Radiol       Date:  2017-12-15       Impact factor: 2.419

6.  Stage 0 osteonecrosis of the jaw in a patient on denosumab.

Authors:  Tara L Aghaloo; Sarah M Dry; Sanjay Mallya; Sotirios Tetradis
Journal:  J Oral Maxillofac Surg       Date:  2014-01-04       Impact factor: 1.895

7.  Osteonecrosis of the jaw a new complication related to Ipilimumab.

Authors:  Adepitan A Owosho; Michael Scordo; SaeHee K Yom; Joseph Randazzo; Paul B Chapman; Joseph M Huryn; Cherry L Estilo
Journal:  Oral Oncol       Date:  2015-10-05       Impact factor: 5.337

8.  Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures.

Authors:  Gioacchino Catania; Federico Monaco; Giulia Limberti; Manuela Alessio; Iolanda De Martino; Cecilia Barile; Antonella Fasciolo; Anna Baraldi; Marco Ladetto; Vittorio Fusco
Journal:  Dent J (Basel)       Date:  2016-12-01

9.  Osteonecrosis of the Jaw Beyond Bisphosphonates: Are There Any Unknown Local Risk Factors?

Authors:  Johann Lechner; Volker von Baehr; Bernd Zimmermann
Journal:  Clin Cosmet Investig Dent       Date:  2021-01-19

10.  Decreasing frequency of osteonecrosis of the jaw in cancer and myeloma patients treated with bisphosphonates: the experience of the oncology network of piedmont and aosta valley (north-Western Italy).

Authors:  Vittorio Fusco; Claudia Galassi; Alfredo Berruti; Cinzia Ortega; Libero Ciuffreda; Matteo Scoletta; Franco Goia; Mario Migliario; Anna Baraldi; Mario Boccadoro; Anastasios Loidoris; Oscar Bertetto
Journal:  ISRN Oncol       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.